Icon close



Steve Cummings is a counsel on the Contracts and Business Torts Practice.  Steve represents national and international corporations in government investigations involving federal and state agencies and regulatory authorities, as well as civil litigation relating to the investigations.  He also provides regulatory advice to pharmacy and health care clients and conducts internal compliance review to assess the effectiveness of a company’s policies, procedures and monitoring programs in meeting regulatory obligations.  And he has represented corporate clients in complex civil matters, including class actions and multi-district litigation, in various federal and state courts.


  • Pharmacies on the Front Line in the War Against Rx Abuse, Chain Drug Review (August 10, 2015)
  • The Ryan Haight Act and Other Regulatory Challenges to the Practice of Telemedicine, AHLA In-House Counselor (June 2015)
  • Significance and Impact of DEA’s Recent Rescheduling of Hydrocodone Combination Drugs, AHLA Health Lawyers Weekly (September 2014)
  • Navigating the Rapidly Changing Regulatory Landscape for Prescription Pain Medications, AHLA In-House Counselor (October 2013)


  • The Buck Stops Here: The Regulatory Landscape Affecting Pharmacy Marketing and Reimbursement, American Society of Pharmacy Law’s 26th Annual Developments in Pharmacy Law (November 15, 2015)
  • The Changing Regulatory Environment for Pain Medications, K&S Pharma U (November 19, 2013)
  • Therapies for Pain, K&S Healthcare Roundtable (January 11, 2013)
Full Bio


Article · Source: Chain Drug Review

July 27, 2020
Epidemics collide: the coronavirus and opioid abuse

Article · Source: Chain Drug Review

April 27, 2020
COVID-19 pandemic sparks regulatory changes for Rx

Article · Source: Chain Drug Review

August 15, 2019
Cannabis-Based Product Rules Continue to Vary

View all


J.D., Emory University, cum laude

B.A., University of Virginia


American Bar Association

Atlanta Bar Association

State Bar of Georgia